CHEST Annual Meeting
To investigate the efficacy and safety of lefamulin in patients with CABP who have or may be at risk for severe pneumonia, the researchers analyzed pooled data from the LEAP 1 and 2 trials based on whether infiltrates were unilobar or multilobar.
To assess the appropriateness of azithromycin prescription for in-patients with CAP at a hospital in New South Wales, the research team retrospectively analyzed severity scores at admission for 100 patients who had been prescribed azithromycin.
To evaluate trends in the susceptibility of S pneumoniae to antimicrobial agents, the researchers collected nearly 8000 isolates from 28 US medical centers from 2011 to 2020 and tested them for susceptibility to ceftaroline and comparator agents.
In this video, Antonio Anzueto, MD, gives an overview of his team's study that compared fluticasone furoate/umeclidinium/vilanterol in a single inhaler with tiotropium among patients with symptomatic COPD, who are at risk of exacerbations.